Johnson & Johnson’s Cerenovus recently announced it has launched its new stroke solutions platform that includes three devices for clot removal procedures. The three devices are designed to aid physicians in performing mechanical thrombectomy procedures. The devices include the Cerebase DA Guide Sheath, Cerenovus Large Bore Catheter and Embotrap III Revascularization Device. Get the full […]
J&J’s Ethicon touts surgical stapler study
Ethicon — part of Johnson & Johnson (NYSE:JNJ) — is highlighting new study results in which its Echelon powered stapler with gripping surface technology (GST) had a lower rate of bleeding-related complications than a competing Medtronic product. Ethicon funded the peer-reviewed study, which appears online in Medical Devices: Evidence and Research. The study compared the Echelon […]
The most innovative pharmaceutical agents of 2020
The Galien Foundation recently announced nominees for most innovative pharmaceutical agents for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical, pharmaceutical drugs and medical technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, […]
Johnson & Johnson to take its time on general surgery robot
Johnson & Johnson (NYSE:JNJ) has decided not to follow a 510(k) clearance pathway for its planned general surgery robot — with a goal to start first-in-human studies with the system by the second half of 2022. That was one of the major pieces of information to come out of the New Brunswick, N.J.–based company’s quarterly earnings […]
Johnson & Johnson Q2 results beat The Street, medical device sales down a third
Johnson & Johnson (NYSE:JNJ) posted second-quarter results today that beat the consensus forecast on Wall Street — boosting its outlook for the year even as its medical device sales took a big hit from the COVID-19 pandemic. The New Brunswick, N.J.–based medical device and pharmaceutical giant reported profits of $3.6 billion, or $1.36 per share, on […]
J&J accelerates development of its COVID-19 vaccine candidate
Johnson & Johnson (NYSE:JNJ) announced today that its Janssen Pharmaceutical subsidiary has moved up first-in-human clinical trials of its COVID-19 vaccine candidate to late July, versus the previously planned start in September. “Based on the strength of the preclinical data we have seen so far and interactions with the regulatory authorities, we have been able to […]
J&J pledges $10m to fight racism in America
BD CEO also expresses “frustration, anger and dismay over the racial inequality and injustice.” Johnson & Johnson (NYSE:JNJ) this week pledged $10 million this week to fight racism and injustice in the U.S. In a response to the deaths of George Floyd in Minneapolis, Breonna Taylor in Louisville, Ky., and Ahmaud Arbery near Brunswick, Ga., J&J […]
AbbVie gains U.S. nod for $63B Allergan takeover
Pharmaceutical giant AbbVie (NYSE:ABBV) has won U.S. antitrust approval for its purchase of Allergan (NYSE:AGN) for $63 billion in cash and stock. The purchase is seen as a hedge against the impending expiration of U.S. patents on AbbVie’s blockbuster drug, Humira. North Chicago-based AbbVie announced the deal in June 2019, but ran up against U.S. […]
6 medtech execs join White House economic recovery group
Several medtech executives have been named to the White House task force designated by President Donald Trump to provide recommendations on how best to safely reopen the U.S. economy in the wake of the coronavirus pandemic. The Great American Economic Revival healthcare industry group has 27 members, including: Mike Kauffman, CEO of Cardinal Health (NYSE:CAH). Brian […]
J&J beats The Street but lowers outlook for 2020
Johnson & Johnson (NYSE:JNJ) beat analysts’ expectations for sales and earnings in the first quarter of 2020, but lowered its financial outlook for the year due to the coronavirus pandemic. The New Brunswick, N.J.-based company reported profits of $6.154 billion, or $2.30 per share, on sales of $20.69 billion for the three months ended March 29, 2020, […]
How is coronavirus vaccine development going in the U.S.?
Researchers in Pittsburgh and Boston are moving forward with research into two separate vaccine programs against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. The work of the University of Pittsburgh School of Medicine researchers is detailed in a paper published recently in EBioMedicine, which is published by the Lancet. Delivery of the vaccine involved a microneedle array to […]
